The analysis of the energetic profile of AML cells showed that resistance of AML patients to with PTPN11 mutations is related to compensatory mechanisms that restore sufficient levels of OXPHOS, related to the presence in these leukemic cells of elevated MCL-1 levels [390]. Here, MCL1 is linked to acute myeloid leukemia.